El interés en corto de GCT Semiconductor Hldgs da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de GCT Semiconductor Hldgs. Los datos de interés en corto se actualizan cada dos semanas.

GCT Semiconductor Hldgs (NYSE:GCTS) Bolsa, Informe de interés en corto

GCT Semiconductor Hldgs

GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Holding Inc

GCT Semiconductor Holding, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

South Bow Corp. ((TSX &amp;, NYSE:<a href="https://www.benzinga.com/stock/SOBO#NYSE">SOBO</a>) has received an unsolicited "mini-tender" offer from TRC Capital Investment Corp. (TRC Capital) to purchase up to 3 million South Bow common shares, or approximately 1.4% of South Bow's outstanding common shares, at a below-market price of C$31.95. South Bow does not endorse TRC Capital's unsolicited offer, has no affiliation with TRC Capital or its offer, and does not recommend or endorse this unsolicited mini-tender offer.
South Bow cautions shareholders that the mini-tender offer has been made at a below-market price for the South Bow common shares. TRC Capital's unsolicited offer price of C$31.95 per share represents a discount of 4.6% to the closing price of the South Bow common shares on the Toronto Stock Exchange and the New York Stock Exchange on Oct. 28, 2024, the last trading day before the mini-tender offer was commenced, and a discount of 7.4% to the closing price on Nov. 1, 2024.

News

Management

SOBO

South Bow Recommends Shareholders Reject TRC Capital's Below-Market "Mini-tender" Offer To Purchase Up To 3M Shares, Or ~1.4% Of South Bow's Outstanding Common Shares, At A Price Of C$31.95 Per Share

As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ:&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4293294-1&amp;h=2469645923&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fapx-acquisition-corp-i-receives-nasdaq-notice-on-late-filing-of-its-form-10-q-302023280.html%23financial-modal&amp;a=APXI">APXI</a>) (the "Company"), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the "Rule"), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the "Notice"). The Company subsequently submitted a plan to regain compliance with the Rule (the "Compliance Plan").
On October 29, 2024, the Company received written notice from the Staff (the "November Notice"), stating that the Compliance Plan was not accepted as the Company had provided insufficient evidence to demonstrate that it can effect the Compliance Plan by its 36-month expiration date of December 6, 2024, at which time the Company's securities will be delisted from Nasdaq in accordance with IM-5101-2, irrespective of the Company's progress or lack thereof toward regaining compliance with the Rule, and that the Staff had determined to initiate procedures to delist the Company's warrants (and, as a result of the warrants' inclusion therein, the Company's units) from Nasdaq due to the Company's non-compliance.
Pursuant to the Notice, unless the Company requests a hearing to appeal this determination by November 5, 2024, the Company's warrants and units will be suspended at the opening of business on November 5, 2024, and a Form 25-NSE will be filed with the SEC, which will remove the Company's warrants and units from listing and registration on Nasdaq (the "Warrant/Unit Delisting"). The Company does not intend to request a hearing. The Warrant/Unit Delisting does not affect the listing or trading of the Company's Class A ordinary shares on the&nbsp;Nasdaq Global Market, other than those contained within the units.

APXI

APXIU

APXIW

APX Acquisition Corp. I Announces Nasdaq Delisting Notification For Warrants And Units

Four Corners Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCPT#NYSE">FCPT</a>), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), is pleased to announce the acquisition of a Miller's Ale House property for $3.8 million. The property is located in a strong retail corridor in Georgia and is corporate-operated under a long term, net lease with approximately 11 years of term remaining. The transaction was priced at a 7.2% cap rate on rent as of the closing date and exclusive of transaction costs.

FCPT

FCPT Announces Acquisition Of A Miller's Ale House Property For $3.8M

- ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients' lives, today announced that results from a Phase 1b/2 combination trial evaluating ALX Oncology's evorpacept in combination with Jazz Pharmaceuticals' zanidatamab in HER2-positive and HER2-low metastatic breast cancer have been accepted for a poster spotlight presentation at the San Antonio Breast Cancer Symposium (SABCS), which will be held in San Antonio, Texas, from December 10-13, 2024.
The Phase 1b/2 clinical trial is a two-part, open-label, multicenter study (<a href="https://www.globenewswire.com/Tracker?data=uP7TgOHeIoBZb8tHT8b8P-5Joh1B-EVwBg4vRKoa2aqEd6K1wLigVjuzGppZ4A3Pcqq8O6QfdpsX2sB5fqmpGS9NQ7SYCSmfS3RFDCelosE=">NCT05027139</a>) that evaluated the potential of evorpacept in combination with zanidatamab as a novel treatment for patients with HER2-expressing breast cancer and other cancers. Data from this study will be summarized in the following poster spotlight presentation:

Biotech

General

ALXO

ALX Oncology Announces Results From Phase 1b/2 Trial Of Evorpacept In Combination With Zanidatamab Will Be Presented At The San Antonio Breast Cancer Symposium 2024

&nbsp;Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) today announced that data from the Phase 3 trial (EMBER-3) for imlunestrant, an oral selective estrogen receptor degrader (SERD), will be reported for the first time in a late-breaking oral presentation at the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4292744-1&amp;h=3267956950&amp;u=https%3A%2F%2Fsabcs.org%2F&amp;a=San+Antonio+Breast+Cancer+Symposium+(SABCS)">San Antonio Breast Cancer Symposium (SABCS)</a> taking place December 10-13 in San Antonio, TX. EMBER-3 is a study in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. The trial is evaluating imlunestrant alone or in combination with Verzenio (abemaciclib; CDK4/6 inhibitor), in patients who were pretreated with endocrine therapy, with or without a CDK4/6 inhibitor.
Lilly will also share results of a real-world analysis of risk of recurrence by nodal status and high-risk features in patients with hormone receptor positive (HR+), HER2- early breast cancer. Additional presentations from investigational mutant selective PI3Ka inhibitor assets include preclinical characterization data for LY4045004, which is expected to enter the clinic in the first half of 2025, and Phase 1a/b clinical data for a predecessor molecule, LOXO-783, which informed the development of LY4045004.

Lilly To Present Results From Phase 3 EMBER-3 Study Of Imlunestrant, An Oral SERD, And Additional Results From Its Breast Cancer Portfolio At The San Antonio Breast Cancer Symposium

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4293554-1&amp;h=3420507561&amp;u=https%3A%2F%2Fwww.centene.com%2F&amp;a=Centene+Corporation">Centene Corporation</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4293554-1&amp;h=1525079035&amp;u=https%3A%2F%2Fwww.buckeyehealthplan.com%2F&amp;a=Buckeye+Health+Plan">Buckeye Health Plan</a>&nbsp;(Buckeye), has been selected by the Ohio Department of Medicaid (ODM) to continue providing Medicare and Medicaid services for dually eligible individuals through a Fully Integrated Dual Eligible Special Needs Plan (FIDE SNP). FIDE SNPs fully integrate care for dually eligible beneficiaries under a single managed care organization, allowing enrollees to receive all of their medical, behavioral and long-term services and supports through one plan.

Centene's Buckeye Health Plan Awarded Contract To Serve Dual Eligible Medicare And Medicaid Members In Ohio

Macro Economic Events

Politics

Economics

STLA

Republican Nominee Donald J. Trump Says 'Tell Stellantis If They Plan On Moving, We're Going To Charge Them A 100% Tariff On Every Car'

Contracts

GRYP

Gryphon Digital Mining & Unit Notified Coinmint Of Their Non-Renewal Of Colocation Mining Services Agreement Dated July 1, 2021

Offerings

PHUN

Phunware Enters Amended And Restated Equity Distribution Agreement; May Offer & Sell Shares For Aggregate Gross Proceeds Up To $171.5M From Time To Time

AIXI

Xiao-I Entered Into Private Placement & Securities Purchase Agreement To Issue, Sell Convertible Promissory Note For $2.1M

LIVN

LivaNova Says CMS Maintains VNS Therapy For DRE At Level 5 APC Under 2025 Medicare Hospital Outpatient Prospective Payment System; Co Will Continue To Pursue Reimbursement Opportunities For VNS Therapy For DRE

Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares traded higher Friday as striking employees are expected to vote on a new contract proposal on Monday, Nov. 4. Here&#8217;s<a href="https://www.benzinga.com/markets/equities/24/11/41676667/boeing-sweetens-deal-with-38-wage-hike-12k-bonus-and-more-to-end-7-week-strike-vote-set-for-mond"> what you need to know.</a>
What To Know: According to<a href="https://aviationweek.com/aerospace/manufacturing-supply-chain/boeing-machinists-reach-new-tentative-deal#:~:text=The%20new%20proposed%20deal%2C%20reached,Boeing%20and%20the%20union%20show."> Aviation Daily</a>, the company announced a tentative deal with the International Association of Machinists (IAM), potentially ending a 49-day strike. This union-recommended agreement proposes a 38% wage increase over four years—13% in the first year, followed by 9% in each of the next two years and 7% in the final year. 
Additionally, workers would receive a $12,000 ratification bonus and improved 401(k) contributions. Boeing also committed to locating any new aircraft production in the Puget Sound region of Washington, a key concession for the union.
This deal comes after union members previously rejected two offers, including a 35% wage increase in October. The initial union request included a 40% wage increase and pension restorations, but the new deal focuses on wage hikes and bonuses, while pensions remain unchanged. If approved, Boeing expects production facilities to gradually reopen as early as Nov. 6, with full staffing anticipated over the following weeks.
The strike and production delays have impacted Boeing's suppliers, with some, like Spirit AeroSystems, already implementing employee furloughs. Boeing CEO Kelly Ortberg emphasized the importance of a careful restart process, citing ongoing issues with production stability and meeting FAA safety standards.
What Else: Boeing&#8217;s rating also remains on S&amp;P&#8217;s CreditWatch following a larger-than-anticipated equity issuance, which helps offset projected cash flow deficits through 2025. However, S&amp;P noted Boeing's limited flexibility for further cash flow pressures and cited ongoing strike-related and post-strike operational risks as areas of concern.
BA Price Action: Boeing shares were up 3.5% at $154.59 on Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="539" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-1024x539.png" alt="" class="wp-image-626219" style="width:451px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-1024x539.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA.png 1441w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/24/11/41693751/biden-can-blame-boeing-for-massive-jobs-data-miss">Biden Can Blame Boeing For Massive Jobs Data Miss</a></li>
</ul>
Photo via Shutterstock.

Movers

Why Boeing Shares Traded Higher On Friday

WIIM

Sherwin-Williams shares are trading higher after it was announced that the company will join the Dow Jones Industrial Average.

NVDA

NVIDIA shares are trading higher after it was announced that the company will join the Dow Jones Industrial Average.

RDZN

Roadzen Files For Mixed Shelf Of Up To $100M

ITRM

Iterum Therapeutics Notified Pfizer, Electing To Defer Milestone Payment For 2 Years For ORLYNVAH, Or Until Oct 25, 2026

The Symplicity &#x2122; blood pressure procedure offers patients a new adjunct approach to lowering blood pressure&nbsp;
GALWAY, Ireland, Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>), a global leader in healthcare technology, today announced that the Centers for Medicare &amp; Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral&#x2122;&nbsp;renal denervation (RDN) catheter, used in the Symplicity&#x2122;&nbsp;blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT payment, which will be effective for up to three years beginning January 1, 2025, aims to support patient access to new and innovative technology, including devices granted Breakthrough Device Designations like the Symplicity Spyral RDN system.

CMS grants Transitional Pass-Through Payment For Medtronic Symplicity Spyral Renal Denervation Catheter; Will Be Effective For Up To Three Years Beginning January 1, 2025

Titan International Files For Offering Of Up To 11.92M Shares By The Selling Stockholders

NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) today announced it has commenced a proposed underwritten public offering in the United States (the "Registered Offering"). Concurrently, the Company has also commenced a private placement (the "Private Offering" and, together with the Registered Offering, the "Offerings").
The Registered Offering consists of common shares and warrants to purchase common shares and is subject to market conditions. There can be no assurance as to whether or when the Registered Offering may be completed, or as to the actual size, pricing or other terms of the Registered Offering. In addition, the Company intends to grant the underwriter a 45-day over-allotment option to purchase up to an additional 15 percent of the number of initial common shares and/or an additional 15 percent of the number of initial warrants offered in the Registered Offering.
The Private Offering consists of common shares and warrants to purchase common shares. There can be no assurance as to whether or when the Private Offering may be completed, or as to the actual size, pricing or other terms of the Private Offering. Completion of the Private Offering is not contingent on completion of the Registered Offering and completion of the Registered Offering is not contingent on the completion of the Private Offering.
Maxim Group LLC is acting as sole book-running manager and underwriter for the Registered Offering.
NioCorp currently intends to use the net proceeds from the Offerings for working capital and general corporate purposes, including to (i) advance its efforts to launch construction of a critical minerals project in Southeast Nebraska (the "Elk Creek Project") and move it to commercial operation and (ii) repay all amounts outstanding under the Company's $2.0 million non-revolving multiple draw credit facility (the "Smith Credit Facility") available pursuant to the Loan Agreement, dated September 11, 2024, by and between the Company and its Chief Executive Officer, President and Executive Chairman, Mark Smith. The Smith Credit Facility will continue to be available to the Company following the close of the Offerings.
The Registered Offering is subject to customary closing conditions.

NioCorp Announces Commencement Of Proposed Underwritten Public Offering Of Common Shares & Warrants; No Size Or Amount Disclosed

CHWY

Chewy shares are trading higher after it was announced that the company will join the S&P MidCap 400 prior to the opening of trading on Wednesday, November 6, 2024.

GCT Semiconductor&nbsp; GAAP EPS of $0.03, revenue of $3.3M

GCT Semiconductor GAAP EPS of $0.03, revenue of $3.3M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into on Monday and we have all of the latest news happening this morning!



Moving stocks this morning are a merger, clinical trial results, insider trading and more.



Let&rsquo;s get into that below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is rocketing more than 123% after <a href="https://www.prnewswire.com/news-releases/big-tree-cloud-and-plutonian-announce-closing-of-business-combination-302166429.html">completing its special purpose acquisition company (SPAC) merger</a> with Plutonian Acquisition.</li>



<li>Nisun (NASDAQ:<a href="https://investorplace.com/stock-quotes/nisn-stock-quote/">NISN</a>) shares are soaring over 19% after announcing a <a href="https://www.nasdaq.com/press-release/nisun-international-announces-significant-breakthrough-egg-business-2024-06-07">breakthrough in its egg business</a>.</li>



<li>Prokidney (NASDAQ:<a href="https://investorplace.com/stock-quotes/prok-stock-quote/">PROK</a>) stock is surging more than 18% on <a href="https://www.nasdaq.com/press-release/prokidney-announces-positive-interim-regen-007-phase-2-trial-data-and-provides">positive Phase 2 clinical trial data</a>.</li>



<li>Logistic Properties of The Americas (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares are gaining over 16% without any clear news this morning.</li>



<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) stock is increasing more than 13% despite a lack of news today.</li>



<li>Veritone (NASDAQ:<a href="https://investorplace.com/stock-quotes/veri-stock-quote/">VERI</a>) shares are rising over 10% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318383347&amp;type=PDF&amp;symbol=VERI&amp;cdn=deec56305788281adbfa6eee05c8e190&amp;companyName=Veritone+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-07">on insider buying</a>.</li>



<li>Gamestop (NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) stock is heading more than 9% higher after <a href="https://www.washingtonpost.com/business/2024/06/07/gamestop-roaring-kitty/">falling 40% on Friday</a>.</li>



<li>KKR &amp; Company LP (NYSE:<a href="https://investorplace.com/stock-quotes/kkr-stock-quote/">KKR</a>) shares are climbing over 8% as it prepares to join the S&amp;P 500 later this month.</li>



<li>Gct Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/gcts-stock-quote/">GCTS</a>) stock is jumping more than 7% today.</li>



<li>Southwest Airlines (NYSE:<a href="https://investorplace.com/stock-quotes/luv-stock-quote/">LUV</a>) shares are up over 6% on Elliott Management reportedly <a href="https://www.reuters.com/markets/deals/elliott-takes-nearly-2-bln-stake-southwest-airlines-wsj-reports-2024-06-09/">taking a large stake</a> in the company.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>China Liberal Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/cleu-stock-quote/">CLEU</a>) stock is diving more than 14% after rallying 58% on Friday.</li>



<li>Biocardia (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcda-stock-quote/">BCDA</a>) shares are tumbling over 12% on Monday morning.</li>



<li>Leafly (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfly-stock-quote/">LFLY</a>) stock is taking a more than 7% beating after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318380573&amp;type=PDF&amp;symbol=LFLY&amp;cdn=4ebce9e0101bf1898be16163857fc95b&amp;companyName=Leafly+Holdings+Inc.&amp;formType=ARS&amp;formDescription=Annual+Report+to+Security+Holders&amp;dateFiled=2024-06-07">rallying Friday on its annual report</a>.</li>



<li>Innate Pharma S.A. ADR (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipha-stock-quote/">IPHA</a>) shares are sliding over 7% this morning.</li>



<li>Terawulf (NASDAQ:<a href="https://investorplace.com/stock-quotes/wulf-stock-quote/">WULF</a>) stock is dropping more than 7% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318383905&amp;type=PDF&amp;symbol=WULF&amp;cdn=a93785096c2256f64532f0f43dcf222b&amp;companyName=TeraWulf+Inc.&amp;formType=4%2FA&amp;formDescription=%5BAmend%5D+Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-07">recent insider trading</a>.</li>



<li>Cerence (NASDAQ:<a href="https://investorplace.com/stock-quotes/crnc-stock-quote/">CRNC</a>) shares are falling over 5% on news it will <a href="https://www.nasdaq.com/press-release/kkr-crowdstrike-holdings-and-godaddy-set-join-sp-500-others-join-sp-midcap-400-and-sp">leave the S&amp;P SmallCap 600</a>.</li>



<li>Red Robin Gourmet Burgers (NASDAQ:<a href="https://investorplace.com/stock-quotes/rrgb-stock-quote/">RRGB</a>) stock is decreasing more than 3% today.</li>



<li>Doximity (NYSE:<a href="https://investorplace.com/stock-quotes/docs-stock-quote/">DOCS</a>) shares are slipping over 3% this morning.</li>



<li>Palantir Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pltr-stock-quote/">PLTR</a>) stock is dipping more than 3% following <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318384096&amp;type=PDF&amp;symbol=PLTR&amp;cdn=9c677294cf3d69082d33fdd0d967bcdf&amp;companyName=Palantir+Technologies+Inc.+Class+A&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-10">shareholder meeting results</a>.</li>



<li>Himalaya Shipping (NYSE:<a href="https://investorplace.com/stock-quotes/hshp-stock-quote/">HSHP</a>) shares close out our pre-market stock movers down 3%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-10th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

In this video, I recap the most recent trading session. I also discuss how to utilize creativity in trading.

Masters In Trading - Saturday, June 15

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning.



Moving stocks are several new deals, delisting notices and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) stock is rocketing more than 153% alongside heavy pre-market trading.</li>



<li>CXApp (NASDAQ:<a href="https://investorplace.com/stock-quotes/cxai-stock-quote/">CXAI</a>) shares are soaring over 61% after <a href="https://www.nasdaq.com/press-release/cxapp-inc-nasdaq-cxai-announces-largest-expansion-deal-strategic-multi-year-0">signing an expansion deal</a> with Google Cloud.</li>



<li>MKDWell Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mkdw-stock-quote/">MKDW</a>) stock is surging more than 57% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318514393&amp;type=PDF&amp;symbol=MKDW&amp;cdn=59d6d4925634abb97d78eb6b63a094fb&amp;companyName=MKDWELL+Tech+Inc.&amp;formType=SC+13D&amp;formDescription=General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-08-12">new investment news</a>.</li>



<li>Pono Capital Two (NASDAQ:<a href="https://investorplace.com/stock-quotes/ptwo-stock-quote/">PTWO</a>) shares are rising over 37% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318512443&amp;type=PDF&amp;symbol=PTWO&amp;cdn=c007f907da889b37797c3a70ef100ef9&amp;companyName=Pono+Capital+Two+Inc.&amp;formType=DEFM14A&amp;formDescription=Definitive+proxy+statement+relating+to+merger+or+acquisition&amp;dateFiled=2024-08-12">proposed merger plan</a>.</li>



<li>Psychemedics (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmd-stock-quote/">PMD</a>) stock is increasing more than 20% on <a href="https://www.nasdaq.com/press-release/psychemedics-corporations-board-directors-approves-plan-terminate-registration-its">plans to delist its shares</a>.</li>



<li>Hesai (NASDAQ:<a href="https://investorplace.com/stock-quotes/hsai-stock-quote/">HSAI</a>) shares are climbing over 19% without any clear news.</li>



<li>Roadzen (NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/">RDZN</a>) stock is heading more than 18% higher despite a lack of news today.</li>



<li>QT Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/qti-stock-quote/">QTI</a>) shares are getting an over 17% boost on Tuesday morning.</li>



<li>Adagio Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/adgm-stock-quote/">ADGM</a>) stock is jumping more than 17% without any recent news.</li>



<li>GCT Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/gcts-stock-quote/">GCTS</a>) shares are up over 17% after <a href="https://www.nasdaq.com/press-release/gct-semiconductor-signs-mou-samsung-accelerate-development-4g-5g-chipsets-and-modules">signing an agreement</a> with Samsung.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Syros Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/syrs-stock-quote/">SYRS</a>) stock is crashing more than 58% on a <a href="https://www.nasdaq.com/press-release/syros-provides-update-select-aml-1-phase-2-clinical-trial-2024-08-12">Phase 2 clinical trial update</a>.</li>



<li>PS International (NASDAQ:<a href="https://investorplace.com/stock-quotes/psig-stock-quote/">PSIG</a>) shares are diving over 21% <a href="https://investorplace.com/2024/08/why-is-ps-international-psig-stock-up-64-today/">after a massive rally yesterday</a>.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) stock is tumbling more than 19% on a <a href="https://finance.yahoo.com/news/sunpower-announces-nasdaq-delisting-notification-205800088.html">Nasdaq delisting notification</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are taking an over 18% beating after rallying yesterday <a href="https://investorplace.com/2024/08/why-is-greenlane-gnln-stock-up-210-today/">on Safety Strips news</a>.</li>



<li>Surf Air Mobility (NYSE:<a href="https://investorplace.com/stock-quotes/srfm-stock-quote/">SRFM</a>) stock is sliding more than 18% after announcing an <a href="https://www.tipranks.com/news/company-announcements/surf-air-mobility-announces-optimistic-ai-joint-venture">artificial intelligence (AI) joint venture</a>.</li>



<li>HNR Acquisition (NYSEMKT:<a href="https://investorplace.com/stock-quotes/hnra-stock-quote/">HNRA</a>) shares are decreasing close to 16% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511957&amp;type=PDF&amp;symbol=HNRA&amp;cdn=eb4e7e579bfe6b9a9328f0eca81fc1b2&amp;companyName=HNR+Acquisition+Corp+Class+A&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-08-12">proposed secondary offering</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) stock is retreating over 15% <a href="https://investorplace.com/2024/08/fsd-pharma-is-up-216-today-what-is-going-on-with-huge-stock/">after a Monday rally</a>.</li>



<li>Interactive Strength (NASDAQ:<a href="https://investorplace.com/stock-quotes/trnr-stock-quote/">TRNR</a>) shares are dropping more than 15% <a href="https://investorplace.com/2024/08/why-is-interactive-strength-trnr-stock-up-59-today/">following a rally yesterday</a>.</li>



<li>Yatra Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/ytra-stock-quote/">YTRA</a>) stock is falling over 14% on a <a href="https://www.tipranks.com/news/company-announcements/yatra-online-reports-mixed-quarterly-performance">mixed earnings report</a>.</li>



<li>Conifer (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnfr-stock-quote/">CNFR</a>) shares are down more than 12% ahead of an <a href="https://www.nasdaq.com/press-release/conifer-holdings-schedules-second-quarter-2024-earnings-conference-call-webcast">earnings conference call tomorrow</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-aug-13th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
GCT Semiconductor Hldgs (NYSE:<a href="https://investorplace.com/stock-quotes/gcts-stock-quote/">GCTS</a>) just reported results for the second quarter of 2024.<ul><li>GCT Semiconductor Hldgs reported earnings per share of -2 cents.</li><li>The company reported revenue of $1.47 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/gcts-stock-earnings-gct-semiconductor-hldgs-for-q2-of-2024/">GCTS Stock Earnings: GCT Semiconductor Hldgs Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GCTS Stock Earnings: GCT Semiconductor Hldgs Reported Results for Q2 2024

GCT Semiconductor&nbsp; GAAP EPS of -$0.02, revenue of $1.47M

GCT Semiconductor Holding (GCTS) just unveiled an update. GCT Semiconductor Holding, Inc.'s Compensation Committee has updated the executive retent...

GCT Semiconductor Updates Executive Retention and Severance Plan

GCT Semiconductor gains as B. Riley starts coverage with Buy

GCT Semiconductor's 5G Push Presents A High Growth Opportunity

ADGM

BCDA

CLEU

CNFR

CORZ

CRNC

CXAI

DOCS

GCTS

GNLN

HNRA

HSAI

HSHP

HUGE

IPHA

LFLY

MKDW

NISN

PENN

PLTR

PROK

PSIG

PTWO

RRGB

SPWR

SRFM

SYRS

TRNR

VERI

WULF

YTRA

Press Releases

GCT Semiconductor and Kyocera Sign Development and Partnership Agreement for Collaboration on a 5G Reference Platform for CPE Devices

Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference

GCT Semiconductor and Ligado Networks Announce Commercial Availability of Band 54 Modules

GCT Semiconductor Holding, Inc. to Announce Second Quarter Financial Results and Hold Conference Call on August 14, 2024

GCT Semiconductor Signs MOU with Samsung to Accelerate the Development of 4G/5G Chipsets and Modules

GCT Semiconductor Holding, Inc. Reports Second Quarter 2024 Financial Results

GCT Semiconductor Holding, Inc. Signs MOU with Global Tier One Telecommunications Supplier

GCT Semiconductor Holding, Inc. to Present at the 2024 Gateway Conference on September 4th

Strategic Partnership of Five Tech Leaders for End-to-End Solutions Within 450MHz Ecosystems

GCT Semiconductor Holding, Inc. to Announce Third Quarter Financial Results and Hold Conference Call on November 14, 2024

ACNT

AERT

AEYE

AIRG

AMPX

AMRK

ARQQ

ASPN

ATEX

BBSI

BKSY

BNZI

BREZ

BTBT

BYRN

CPSS

DEFTF

DUOT

ELVA

FTHM

GAIA

GENK

HEAR

HTCR

JTAI

LINK

LTRX

MAPPF

MIGI

MIMOQ

MYPS

NATR

OOMA

PRLB

PXDT

QTRHF

QUISF

SNCR

SNPO

SOWG

SSTI

TRUE

TSX:KITS

TSX:QTRH

TSX:QUIS

TYGO

VTSI

WKHS

ZCAR

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

Kopin

SEALSQ

SemiLEDs

Maxeon Solar Technologies, Ltd. - Ordinary Shares

Maxeon Solar Technologies

Mobix Labs

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

Nano Labs

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Peraso

Pixelworks

QuickLogic

Rigetti Computing

Semilux International Ltd. - Ordinary Shares

Semilux International

SkyWater Technology

SmartKem

SPI Energy

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

GCT Semiconductor Hldgs

Interés en corto

GCT Semiconductor Hldgs (NYSE:GCTS) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL